The effects of meclofenoxate on cognitiv
β
Dr. S. J. Harris; J. H. Dowson
π
Article
π
1986
π
John Wiley and Sons
π
English
β 397 KB
π 2 views
Twenty residents with mild to moderate memory impairment probably due to senile dementia of Alzheimer type entered a placebo-controlled, double-blind, crossover trial of meclofenoxate 600 mg administered twice daily for 12 weeks. Nine subjects completed the trial during which various tests of cognit